SE9801617D0 - New compound - Google Patents

New compound

Info

Publication number
SE9801617D0
SE9801617D0 SE9801617A SE9801617A SE9801617D0 SE 9801617 D0 SE9801617 D0 SE 9801617D0 SE 9801617 A SE9801617 A SE 9801617A SE 9801617 A SE9801617 A SE 9801617A SE 9801617 D0 SE9801617 D0 SE 9801617D0
Authority
SE
Sweden
Prior art keywords
protein
testis
nucleic acid
acid sequence
fetal
Prior art date
Application number
SE9801617A
Other languages
Swedish (sv)
Inventor
Katarina Nordqvist
Virpi Toehoenen
Original Assignee
Karolinska Innovations Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karolinska Innovations Ab filed Critical Karolinska Innovations Ab
Priority to SE9801617A priority Critical patent/SE9801617D0/en
Publication of SE9801617D0 publication Critical patent/SE9801617D0/en
Priority to PCT/SE1999/000764 priority patent/WO1999058565A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

A gene encoding a novel cystatin-related protein has been isolated from fetal male mouse gonad and adult male human testis. The novel protein has a potential role in inducing testis formation in fetal gonads. It is also highly probable that the protein inhibits testis tumor growth because of structural and functional similarities with tumor inhibiting cystatins. The corresponding nucleic acid sequence, as well as vectors and host cells containing the nucleic acid sequence, and pharmaceutical compositions containing the protein are also claimed.
SE9801617A 1998-05-08 1998-05-08 New compound SE9801617D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE9801617A SE9801617D0 (en) 1998-05-08 1998-05-08 New compound
PCT/SE1999/000764 WO1999058565A1 (en) 1998-05-08 1999-05-06 Cystatin-related protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9801617A SE9801617D0 (en) 1998-05-08 1998-05-08 New compound

Publications (1)

Publication Number Publication Date
SE9801617D0 true SE9801617D0 (en) 1998-05-08

Family

ID=20411238

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9801617A SE9801617D0 (en) 1998-05-08 1998-05-08 New compound

Country Status (2)

Country Link
SE (1) SE9801617D0 (en)
WO (1) WO1999058565A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7109292B2 (en) * 1999-03-08 2006-09-19 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2441601A (en) * 1999-12-23 2001-07-03 Zymogenetics Inc. Zcys5: a member of the cystatin superfamily
AU2001279182A1 (en) * 2000-08-07 2002-02-18 Zymogenetics Inc. Zcys9: a member of the cystatin superfamily
AU2001286871A1 (en) * 2000-09-01 2002-03-22 Zymogenetics Inc. Mammalian cystatin-8 and its use to inhibit cancer procoagulant protein
EP1343813A4 (en) * 2000-12-19 2004-11-17 Smithkline Beecham Corp Novel compounds
CN100368018C (en) * 2005-05-26 2008-02-13 福建医科大学 Fumor invasion and metastasis resisting function and use of venin cysteine proteinase inhibitor

Also Published As

Publication number Publication date
WO1999058565A8 (en) 2000-01-06
WO1999058565A1 (en) 1999-11-18

Similar Documents

Publication Publication Date Title
ATE75483T1 (en) OLIGONUCLEOTIDE REMEDY AND ITS PRODUCTION PROCESS.
DE69231001D1 (en) UBIQUIT-SPECIFIC PROTEASES
IT1304152B1 (en) COMPOSITIONS INCLUDING A PEPTIDE AND POLYLACTIC-GLYCOLIC ACID FOR THE PREPARATION OF SUBCUTANEOUS IMPLANTS HAVING A PROLONGED
NO175601C (en) Liquid, enzyme-containing mixture, as well as process for its preparation
EP0165033A3 (en) Conformationally restricted thymopentin-like compounds
HUT61202A (en) Process for producing pharmaceutical compositions neutralizing procoagulant activity caused by tumour cells
DK0804558T3 (en) tripeptidyl aminopeptidase
HU9201789D0 (en) Process for the production of substituted diamino-phtalimides and their analogues
AR008847A1 (en) NUCLEIC ACID CONSTRUCTIONS FOR THE REGULATED EXPRESSION OF A TRANSGEN IN A HOSPITAL CELL FOR USE IN PHENIC THERAPY AND GENETIC LAMANIPULATION, AN ISOLATED CELL THAT COMPREHENS THEM AND A PHARMACEUTICAL COMPOSITION
SE9801617D0 (en) New compound
EP0232523A3 (en) Dna sequences which encode for proteins with the biological activity of husi-type i inhibitors, their production by gene technology and drugs containing these proteins
HUP9800613A2 (en) Humanized antibody against human fas-antigene
IL116026A0 (en) Peptides capable of linking to the sh3 domain of gap nucleotide sequences encoding the same their preparation and uses
ES2003112A6 (en) Peptide antagonists of Neurokinin B and opthalmic solutions containing them.
DK167384D0 (en) PENEMES, PHARMACEUTICAL PREPARATIONS CONTAINING THESE, AND PROCEDURES FOR PRODUCING THEREOF
Singh et al. Investigation of some biochemical genetic markers in four endogamous groups from Panjab (NW India) I. Protein and enzyme polymorphisms in serum
EA199900256A1 (en) NUCLEOTIDE AND PROTEIN SEQUENCE OF MAMMASTATINE AND METHODS OF APPLICATION
DK1007647T3 (en) High-level expression of INGAP
SE8804607L (en) WATER FORMULATIONS CONTAINING A PIPERIDINYLYCYLOPENTYLPHENONIC ACID DERIVATIVE
FI102085B1 (en) Procedure for in vitro analysis of allergies caused by metals
NO20005321L (en) Host-encoded protein expressed in Marek's disease (MDV) infected cells and antibodies thereto
DK162440C (en) PYRAZINDIAZOHYDROXIDE COMPOUNDS
IT8621261A0 (en) PHARMACEUTICAL COMPOSITIONS FOR THE THERAPY OF PATHOPHYSIOLOGICAL STATES WITH INCREASED PROTEIN CATABOLISM.
KR870700093A (en) Recombination Method for the Preparation of Serine Protease Inhibitors and Useful DNA Sequences
IT8721455A0 (en) PHARMACEUTICAL COMPOSITIONS FOR THE THERAPY OF PATHOPHYSIOLOGICAL STATES WITH INCREASED PROTEIN CATABOLISM.